Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas
Analytical Cellular Pathology · 2024-01 · 2024 (1)
DOI: 10.1155/2024/5573892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Cellular Pathology, online erschienen am 02.08.2024. Verfasst von Antonio Ieni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy. Hauptthemen laut MEDLINE: Meningioma, Sequestosome-1 Protein, Immunohistochemistry, Neoplasm Grading. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Among autophagic‐related proteins, p62/SQSTM1/Sequestosome‐1 represents a relevant actor in cellular proliferation and neoplastic growth. Although, recently, p62 expression has been analyzed in different neurodegenerative and glial neoplastic diseases, no available information have been reported in meningiomas, which have an high epidemiological relevance being the second most common category of intracranial tumors after gliomas. Generally meningiomas have a benign behavior, but their recurrence is not uncommon mainly when atypical or anaplastic varieties occur. However, intranuclear vacuoles have been ultrastructurally observed in meningiomas, and they were labelled by p62 antibodies. Therefore, in the present study, we have investigated p62 immunohistochemical pattern in a cohort of 133 cases representative of low‐ and high‐grade meningiomas, to verify if p62 expression may be related to clinicopathological data, thus achieving a potential prognostic role. The p62 immunoexpression was frequently found in the nucleus and cytoplasm of neoplastic elements, and utilizing an intensity‐distribution score, 55 (41.3%) cases were considered as high expressors while 78 (58.7%) cases were instead recorded as low expressors. Fifteen cases exhibited recurrences of the disease, 14 of which were codified as high expressors. Moreover, a direct relationship between p62 and Mib‐1 immunoexpression as well as between p62 and neoplastic grade have been documented. Finally, we suggest that impaired autophagic flux with an increase in p62 expression may be involved in the activation of NRF2 also contributing in the development of recurrence in meningioma patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy.
- Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, Neurosurgery University of Messina, Viale Gazzi, Messina 98125, Italy.
ORCID-Profile: Antonio Ieni, Cristina Pizzimenti, Vincenzo Fiorentino, Maurizio Martini, Guido Fadda, Giovanni Tuccari
Zitieren
APA
Ieni, A., Pizzimenti, C., Fiorentino, V., Franchina, M., Germanò, A., Raffa, G., Martini, M., Fadda, G., & Tuccari, G. (2024). Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas. Analytical Cellular Pathology, 2024(1). https://doi.org/10.1155/2024/5573892
Vancouver
Ieni A, Pizzimenti C, Fiorentino V, Franchina M, Germanò A, Raffa G, et al. Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas. Analytical Cellular Pathology. 2024;2024(1). doi:10.1155/2024/5573892
BibTeX
@article{Ieni2024,
author = {Ieni, Antonio and Pizzimenti, Cristina and Fiorentino, Vincenzo and Franchina, Mariausilia and Germanò, Antonino and Raffa, Giovanni and Martini, Maurizio and Fadda, Guido and Tuccari, Giovanni},
title = {Immunohistochemical Profile of p62/SQSTM1/Sequestosome‐1 in Human Low‐ and High‐Grade Intracranial Meningiomas},
journal = {Analytical Cellular Pathology},
year = {2024},
volume = {2024},
number = {1},
doi = {10.1155/2024/5573892}
}
EUVIMED